911. Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U . (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1-9. Advance online
publication. https://doi.org/10.1007/s00392-020-01704-y. Clin Res Cardiol, 110(8), 1352. doi:10.1007/s00392-021-01896-
x. https://www.ncbi.nlm.nih.gov/pubmed/34170372
912. Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., . . .
Montastruc, F. (2021). Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes. doi:10.1093/ehjqcco/qcab090. https://www.ncbi.nlm.nih.gov/pubmed/34849667
913. Forgacs, D., Jang, H., Abreu, RB, Hanley, HB, Gattiker, JL, Jefferson, AM, & Ross, TM (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans. Front Immunol, 12, 728021. doi:10.3389/fimmu.2021.728021. https://www.ncbi.nlm.nih.gov/pubmed/34646267
914. Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., . . .
Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicenter study. Ann Rheum Dis, 80(10), 1330-1338. doi:10.1136/annrheumdis-2021-
220647. https://www.ncbi.nlm.nih.gov/pubmed/34127481
915. Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials. Pediatrician Clin North Am, 68
doi:10.1016/j.pcl.2021.05.004. https://www.ncbi.nlm.nih.gov/pubmed/34538306
916. Gargano, JW, Wallace, M., Hadler, SC, Langley, G., Su, JR, Oster, ME, . . . Oliver, S.E. (2021). Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021. MMWR Morb Mortal Wkly Rep, 70(27), 977-982.
doi:10.15585/mmwr.mm7027e2. https://www.ncbi.nlm.nih.gov/pubmed/34237049 917. Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I.
(2021). Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel), 9(1). doi:10.3390/vaccines9010019. https://www.ncbi.nlm.nih.gov/pubmed/33406694
918. Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). A Late Presentation of COVID-19 Vaccine-Induced Myocarditis. Cureus,
13(9), and 17890.
doi:10.7759/cureus.17890. https://www.ncbi.nlm.nih.gov/pubmed/34660088
919. Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. B.M.J., 375, n3090. doi:10.1136/bmj.n3090. https://www.ncbi.nlm.nih.gov/pubmed/34916217
920. Greenhawt, M., Abrams, EM, Shaker, M., Chu, DK, Khan, D., Akin, C., . . .
Golden, DBK (2021). The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract, 9
doi:10.1016/j.jaip.2021.06.006. https://www.ncbi.nlm.nih.gov/pubmed/34153517 921. Haaf, P., Kuster, GM, Mueller, C., Berger, CT, Monney, P., Burger, P., . . .
Tanner, F.C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Med Wkly, 151, w30087.
doi:10.4414/smw.2021.w30087. https://www.ncbi.nlm.nih.gov/pubmed/34668687 922. Hasnie, AA, Hasnie, UA, Patel, N., Aziz, MU, Xie, M., Lloyd, SG, &
Prabhu, S.D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disorder, 21(1), 375. doi:10.1186/s12872-021-02183-
3. https://www.ncbi.nlm.nih.gov/pubmed/34348657
923. Hause, AM, Gee, J., Baggs, J., Abara, WE, Marquez, P., Thompson, D., . . . Shay, D.K. (2021). COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years – United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep, 70
doi:10.15585/mmwr.mm7031e1. https://www.ncbi.nlm.nih.gov/pubmed/34351881 924. Helms, JM, Ansteatt, KT, Roberts, JC, Kamatam, S., Foong, KS, Labayog,
J.S., & Tarantino, MD (2021). Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med, 12, 221-224. doi:10.2147/JBM.S307047. https://www.ncbi.nlm.nih.gov/pubmed/33854395
925. Hippisley-Cox, J., Patone, M., Mei, XW, Saatci, D., Dixon, S., Khunti, K., . . . Coupland, C.A.C. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. B.M.J., 374, n1931.
doi:10.1136/bmj.n1931. https://www.ncbi.nlm.nih.gov/pubmed/34446426
926. Ho, JS, Sia, CH, Ngiam, JN, Loh, PH, Chew, NW, Kong, WK, & Poh,
KK (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J.
doi:10.11622/smedj.2021210. https://www.ncbi.nlm.nih.gov/pubmed/34808708
927. Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinosh*ta, N., & Sato,
D (2021). Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Drug Saf, 44(11), 1209-1214. doi:10.1007/s40264-021-01104-
9. https://www.ncbi.nlm.nih.gov/pubmed/34347278
928. In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines. (2021). Med Lett Drugs Ther, 63(1629), e9. Retrieved
from https://www.ncbi.nlm.nih.gov/pubmed/34544112https://www.ncbi.nlm.nih.gov/p ubmed/34544112
929. Ioannou, A. (2021a). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19
vaccination. QJM.
doi:10.1093/qjmed/hcab231. https://www.ncbi.nlm.nih.gov/pubmed/34463755 930. Ioannou, A. (2021b). T2 mapping should be used in cases of suspected
myocarditis to confirm an acute inflammatory process. QJM. doi:10.1093/qjmed/hcab326. https://www.ncbi.nlm.nih.gov/pubmed/34931681
931. Isaak, A., Feisst, A., & Luetkens, JA (2021). Myocarditis Following COVID-19 Vaccination. Radiology, 301(1), E378-E379.
doi:10.1148/radiol.2021211766. https://www.ncbi.nlm.nih.gov/pubmed/34342500 932. Istampoulouoglou, I., Dimitriou, G., Spani, S., Christ, A., Zimmermanns, B.,
Koechlin, S., . . . Leuppi-Taegtmeyer, AB (2021). Myocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center. Glob Cardiol Sci Pract, 2021(3), e202118. doi:10.21542/gcsp.2021.18. https://www.ncbi.nlm.nih.gov/pubmed/34805376
933. Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., . . . La Scola, B. (2021). High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2. Viruses, 13(11). doi:10.3390/v13112177. https://www.ncbi.nlm.nih.gov/pubmed/34834983
934. Jain, SS, Steele, JM, Fonseca, B., Huang, S., Shah, S., Maskatia, SA, . . . Grosse-Wortmann, L. (2021). COVID-19 Vaccination-Associated Myocarditis in Adolescents. Pediatrics, 148(5). doi:10.1542/peds.2021-
053427. https://www.ncbi.nlm.nih.gov/pubmed/34389692
935. Jhaveri, R., Adler-Shohet, FC, Blyth, CC, Chiotos, K., Gerber, JS, Green, M.,
. . . Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc, 10(10), 937-939. doi:10.1093/jpids/piab061. https://www.ncbi.nlm.nih.gov/pubmed/34270752
936. Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease- 2019 (COVID-19). Circ J. doi:10.1253/circj.CJ-21-
0818. https://www.ncbi.nlm.nih.gov/pubmed/34744118
937. Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., . . . Panza, JA (2021). Myocarditis following COVID-19 vaccination. Int J Cardiol Heart Vasc, 36, 100872.
doi:10.1016/j.ijcha.2021.100872. https://www.ncbi.nlm.nih.gov/pubmed/34568540 938. Khogali, F., & Abdelrahman, R. (2021). Unusual Presentation of Acute
Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination. Cureus, 13(7), and 16590.
doi:10.7759/cureus.16590. https://www.ncbi.nlm.nih.gov/pubmed/34447639
939. Kim, HW, Jenista, ER, Wendell, DC, Azevedo, CF, Campbell, MJ, Darty,
SN, . . . Kim, R.J. (2021). Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol, 6(10), 1196-1201. doi:10.1001/jamacardio.2021.2828. https://www.ncbi.nlm.nih.gov/pubmed/34185046
940. Kim, IC, Kim, H., Lee, HJ, Kim, JY, & Kim, JY (2021). Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination. J Korean Med Sci, 36(32), and 229.
doi:10.3346/jkms.2021.36.e229. https://www.ncbi.nlm.nih.gov/pubmed/34402228 941. King, WW, Petersen, MR, Matar, RM, Budweg, JB, Cuervo Pardo, L., &
Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. Am Heart J Plus, 8, 100042.
doi:10.1016/j.ahjo.2021.100042. https://www.ncbi.nlm.nih.gov/pubmed/34396358kle
in, NP, Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, KE, . . . Weintraub, ES (2021). Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA, 326
doi: 10.1001 / jama.2021.15072. https://www.ncbi.nlm.nih.gov/pubmed/34477808 942. Klimek, L., Bergmann, KC, Brehler, R., Pfutzner, W., Zuberbier, T., Hartmann,
K., . . . Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and OGAI. Allergo J Int, 1-17. doi:10.1007/s40629-021-00165-
7. https://www.ncbi.nlm.nih.gov/pubmed/33898162
943. Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., . .
. Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA). Allergo J Int, 30(2), 51-55. doi:10.1007/s40629-020-00160-4. https://www.ncbi.nlm.nih.gov/pubmed/33643776
944. Kohli, U., Desai, L., Chowdhury, D., Harahsheh, AS, Yonts, AB, Ansong, A., .
. . Ang, J.Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. J Pediatr.
doi:10.1016/j.jpeds.2021.12.025. https://www.ncbi.nlm.nih.gov/pubmed/34952008 945. Kostoff, RN, Calina, D., Kanduc, D., Briggs, MB, Vlachoyiannopoulos, P.,
Svistunov, A. A., & Tsatsakis, A. (2021a). Erratum to “Why are we vaccinating children against COVID-19?” [Toxicol. Rep. 8C (2021) 1665-1684 / 1193]. Toxicol Rep, 8, 1981.
doi:10.1016/j.toxrep.2021.10.003. https://www.ncbi.nlm.nih.gov/pubmed/34642628 946. Kostoff, RN, Calina, D., Kanduc, D., Briggs, MB, Vlachoyiannopoulos, P.,
Svistunov, A. A., & Tsatsakis, A. (2021b). Why are we vaccinating children against COVID-19? Toxicol Rep, 8, 1665-1684.
doi:10.1016/j.toxrep.2021.08.010. https://www.ncbi.nlm.nih.gov/pubmed/34540594 947. Kremsner, PG, Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, JJ,
. . . Group, C.-N.-S. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial. Vienna Klin Wochenschr, 133(17-18), 931-941. doi:10.1007/s00508-021-01922-
y. https://www.ncbi.nlm.nih.gov/pubmed/34378087
948. Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., . . . Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. NatMed, 27(8), 1379-1384. doi:10.1038/s41591-021-01413-7. https://www.ncbi.nlm.nih.gov/pubmed/34127854
949. Kwan, MYW, Chua, GT, Chow, CB, Tsao, SSL, To, KKW, Yuen, K.
Y., . . . Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27
doi:10.12809/hkmj215120. https://www.ncbi.nlm.nih.gov/pubmed/34393110
950. Lee, E., Chew, NWS, Ng, P., & Yeo, TJ (2021). Reply to “Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination”. QJM. doi:10.1093/qjmed/hcab232. https://www.ncbi.nlm.nih.gov/pubmed/34463770
951. Lee, EJ, Cines, DB, Gernsheimer, T., Kessler, C., Michel, M., Tarantino, MD,
. . . Bussel, J.B. (2021). Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol, 96
doi:10.1002/ajh.26132. https://www.ncbi.nlm.nih.gov/pubmed/33606296
952. Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., .
. . Gordon, B. (2021). Myocarditis following COVID-19 vaccination – A case series. Vaccine, 39
doi:10.1016/j.vaccine.2021.09.004. https://www.ncbi.nlm.nih.gov/pubmed/34535317 953. Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., . . . Zhu, F. (2021). Safety
and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1
study. NatMed, 27(6), 1062-1070. doi:10.1038/s41591-021-01330-
9. https://www.ncbi.nlm.nih.gov/pubmed/33888900
954. Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, ZK (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. J Pers Med, 11(11)
doi:10.3390/jpm11111106. https://www.ncbi.nlm.nih.gov/pubmed/34834458
955. Lim, Y., Kim, MC, Kim, KH, Jeong, IS, Cho, YS, Choi, YD, & Lee, JE
(2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Front Cardiovasc Med, 8, 758996. doi:10.3389/fcvm.2021.758996. https://www.ncbi.nlm.nih.gov/pubmed/34778411
956. Long, S.S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, 5. doi:10.1016/j.jpeds.2021.07.057. https://www.ncbi.nlm.nih.gov/pubmed/34332972
957. Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., . . .
McDonald, M. (2021). Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers. Can J Cardiol, 37
doi:10.1016/j.cjca.2021.08.001. https://www.ncbi.nlm.nih.gov/pubmed/34375696 958. Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D.
O., . . . Eberhardt, C.S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Blink Infect Dis. doi:10.1093/cid/ciab954. https://www.ncbi.nlm.nih.gov/pubmed/34791081
959. Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Rep Pediatr, 2021, 6901131. doi:10.1155/2021/6901131. https://www.ncbi.nlm.nih.gov/pubmed/34676123
960. Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., . . . Alexander,
S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. Pediatric Blood Cancer, 68(11), e29295. doi:10.1002/pbc.29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511
961. Martins-Filho, PR, Quintans-Junior, LJ, de Souza Araujo, AA, Sposato, KB, Souza Tavares, CS, Gurgel, RQ, . . . Santos, VS (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. doi:10.1016/j.puhe.2020.11.005. https://www.ncbi.nlm.nih.gov/pubmed/33316478
962. McLean, K., & Johnson, T.J. (2021). Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report. Acad Emerg Med, 28
doi:10.1111/acem.14322. https://www.ncbi.nlm.nih.gov/pubmed/34133825
963. Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, EJ, Nadir, E., . . . Alroy Price, S. (2021). Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in
Israel. N Engl J Med, 385
doi:10.1056/NEJMoa2109730. https://www.ncbi.nlm.nih.gov/pubmed/34614328 964. Minocha, PK, Better, D., Singh, RK, & Hoque, T. (2021). Recurrence of Acute
Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent. J Pediatr, 238, 321-323. doi:10.1016/j.jpeds.2021.06.035. https://www.ncbi.nlm.nih.gov/pubmed/34166671
965. Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., . . .
Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nat Commun, 12(1), 6379. doi:10.1038/s41467-021-26672-
3. https://www.ncbi.nlm.nih.gov/pubmed/34737312
966. Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus Transcriptome in Pediatric Soft Tissue Abscesses and Comparison to Murine Infections. Infect Immune, 89(4). doi:10.1128/IAI.00715-
20. https://www.ncbi.nlm.nih.gov/pubmed/33526560
967. Mohamed, L., Madsen, AMR, Schaltz-Buchholzer, F., Ostenfeld, A., Netea, MG, Benn, CS, & Kofoed, PE (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid vaccines: two case reports. BMC Infect Dis, 21(1), 1264. doi:10.1186/s12879-021-06949-
0. https://www.ncbi.nlm.nih.gov/pubmed/34930152
968. Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., .
. . Cooper, L.T., Jr. (2021). Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol, 6(10), 1202-1206.
doi:10.1001/jamacardio.2021.2833. https://www.ncbi.nlm.nih.gov/pubmed/34185045 969. Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., . . . Ikeda,
T (2021). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Intern Med. doi:10.2169/internalmedicine.8731-
21. https://www.ncbi.nlm.nih.gov/pubmed/34840235
970. Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., . .
. Kaneko, Y. (2021). Acute Myocarditis Associated with COVID-19 Vaccination: A Case Report. J Cardiol Cases.
doi:10.1016/j.jccase.2021.11.006. https://www.ncbi.nlm.nih.gov/pubmed/34876937 971. Ntouros, PA, Vlachogiannis, NI, Pappa, M., Nezos, A., Mavragani, CP,
Tektonidou, MG, . . . Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clin Immunol, 229, 108765. doi:10.1016/j.clim.2021.108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859
972. Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, LS, Hartling, UB, . . .
Stensballe, LG (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e28.
doi:10.1097/INF.0000000000003389. https://www.ncbi.nlm.nih.gov/pubmed/3488987 5
973. Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S.,
. . . Hofmann, M. (2021). Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. doi:10.1038/s41586-021-03841-
4. https://www.ncbi.nlm.nih.gov/pubmed/34320609
974. Park, H., Yun, KW, Kim, KR, Song, SH, Ahn, B., Kim, DR, . . . Kim, YJ
(2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. J Korean Med Sci, 36(32), and 232.
doi:10.3346/jkms.2021.36.e232. https://www.ncbi.nlm.nih.gov/pubmed/34402230
975. Park, J., Brekke, DR, & Bratincsak, A. (2021). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiol Young, 1-4. doi:10.1017/S1047951121002547. https://www.ncbi.nlm.nih.gov/pubmed/34180390
976. Patel, YR, Louis, DW, Atalay, M., Agarwal, S., & Shah, NR (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. J Cardiovasc Magn Reson, 23(1), 101. doi:10.1186/s12968-021-00795-
4. https://www.ncbi.nlm.nih.gov/pubmed/34496880
977. Patone, M., Mei, XW, Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., . . . Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Wet Med. doi:10.1038/s41591-021-01630-
0. https://www.ncbi.nlm.nih.gov/pubmed/34907393
978. Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep, 16(11), 3321-3325.
doi:10.1016/j.radcr.2021.07.082. https://www.ncbi.nlm.nih.gov/pubmed/34367386 979. Perez, Y., Levy, ER, Joshi, AY, Virk, A., Rodriguez-Porcel, M., Johnson, M., .
. . Swift, M.D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Blink Infect Dis.
doi:10.1093/cid/ciab926. https://www.ncbi.nlm.nih.gov/pubmed/34734240
980. Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, AG,
. . . Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Med, 63(3), 324-331. doi:10.23736/S0031-0808.21.04435-
9. https://www.ncbi.nlm.nih.gov/pubmed/34738774
981. Pinana, JL, Lopez-Corral, L., Martino, R., Montoro, J., Vazquez, L., Perez, A., . .
. Cell Therapy, G. (2022). SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol, 97
doi:10.1002/ajh.26385. https://www.ncbi.nlm.nih.gov/pubmed/34695229
982. Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., . . . Andre, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. Eur J Cancer, 154, 30-34. doi:10.1016/j.ejca.2021.06.002. https://www.ncbi.nlm.nih.gov/pubmed/34233234
983. Sanchez Tijmes, F., Thavendiranathan, P., Udell, JA, Seidman, MA, & Hanneman, K. (2021). Cardiac MRI Assessment of Nonischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination. Radiol Cardiothoracic Imaging, 3(6), e210252. doi:10.1148/ryct.210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954
984. Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Mallenahalli Chikkabyrappa, S., & Portman, MA (2021). Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-320.
doi:10.1016/j.jpeds.2021.06.083. https://www.ncbi.nlm.nih.gov/pubmed/34228985 985. Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, HU, Kuhnen, C.,
. . . Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination
with COVID-19 vaccines. Int J Legal Med, 135(6), 2335-2345. doi:10.1007/s00414- 021-02706-9. https://www.ncbi.nlm.nih.gov/pubmed/34591186
986. Schramm, R., Costard-Jackle, A., Rivinius, R., Fischer, B., Muller, B., Boeken, U.,
. . . Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clin Res Cardiol, 110(8), 1142-1149. doi:10.1007/s00392-021-01880-
5. https://www.ncbi.nlm.nih.gov/pubmed/34241676
987. Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. J Clin Med, 10(24)
doi:10.3390/jcm10245876. https://www.ncbi.nlm.nih.gov/pubmed/34945172 988. Sharif, N., Alzahrani, KJ, Ahmed, SN, & Dey, SK (2021). efficiency,
Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Front Immunol, 12, 714170.
doi:10.3389/fimmu.2021.714170. https://www.ncbi.nlm.nih.gov/pubmed/34707602 989. Shay, DK, Gee, J., Su, JR, Myers, TR, Marquez, P., Liu, R., . . .
Shimabukuro, T.T. (2021). Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine – United States, March-April 2021. MMWR Morb Mortal Wkly Rep, 70
doi:10.15585/mmwr.mm7018e2. https://www.ncbi.nlm.nih.gov/pubmed/33956784 990. Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-Year-Old Man
Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case Study. Cureus, 13(7), and 16383.
doi:10.7759/cureus.16383. https://www.ncbi.nlm.nih.gov/pubmed/34408937 991. Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., . . .
Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. doi:10.1093/ehjci/jeab230. https://www.ncbi.nlm.nih.gov/pubmed/34739045
992. Simone, A., Herald, J., Chen, A., Gulati, N., Shen, AY, Lewin, B., & Lee, MS (2021). Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. JAMA Intern Med, 181(12), 1668-1670. doi:10.1001/jamainternmed.2021.5511. https://www.ncbi.nlm.nih.gov/pubmed/34605 853
993. Singer, ME, Taub, IB, & Kaelber, DC (2021). Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based
Analysis. medRxiv.
doi:10.1101/2021.07.23.21260998. https://www.ncbi.nlm.nih.gov/pubmed/34341797 994. Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., . . . Fraser, L.K
(2021). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med. doi:10.1038/s41591-021-01578-
1. https://www.ncbi.nlm.nih.gov/pubmed/34764489
995. Snapiri, O., Rosenberg Danziger, C., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., . . . Bilavsky, E. (2021). Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J, 40(10), e360-e363. doi:10.1097/INF.0000000000003235. https://www.ncbi.nlm.nih.gov/pubmed/3407794 9
996. Spinner, JA, Julien, CL, Olayinka, L., Dreyer, WJ, Bocchini, CE, Munoz, FM, & Devaraj, S. (2021). SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report. J Heart Lung Transplant. doi:10.1016/j.healun.2021.11.001. https://www.ncbi.nlm.nih.gov/pubmed/34911654
997. Starekova, J., Bluemke, DA, Bradham, WS, Grist, TM, Schiebler, ML, & Reeder, SB (2021). Myocarditis Associated with mRNA COVID-19
Vaccination. Radiology, 301(2), E409-E411.
doi:10.1148/radiol.2021211430. https://www.ncbi.nlm.nih.gov/pubmed/34282971 998. Sulemankhil, I., Abdelrahman, M., & Negi, S.I. (2021). Temporal association
between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review. Cardiovasc Revasc Med.
doi:10.1016/j.carrev.2021.08.012. https://www.ncbi.nlm.nih.gov/pubmed/34420869 999. Tailor, PD, Feighery, AM, El-Sabawi, B., & Prasad, A. (2021). Case report:
acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. Eur Heart J Case Rep, 5(8), ytab319.
doi:10.1093/ehjcr/ytab319. https://www.ncbi.nlm.nih.gov/pubmed/34514306
1000. Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021).
Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circ J. doi:10.1253/circj.CJ-21-
